Shares of Ross Stores, Inc. ROST rose sharply in today's pre-market trading after the company reported better-than-expected earnings for its first quarter and increased its profit forecast for the year.
The company posted quarterly revenue of $4.858 billion, versus estimates of $4.833 billion. Earnings came in at $1.46 per share, versus estimates of $1.34 per share, according to data from Benzinga Pro.
Ross Stores shares jumped 8.2% to $142.73 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Netcapital Inc. NCPL rose 105.2% to $0.3587 in today's pre-market trading after jumping 15% on Thursday.
- Akanda Corp. AKAN shares gained 99.2% to $4.76 in pre-market trading after dipping 35% on Thursday.
- Cue Health Inc. HLTH gained 36.4% to $0.1288 in pre-market trading after falling around 12% on Thursday. Cue Health, last week, announced that it voluntarily and temporarily paused sales and distribution of its EUA COVID-19 Test Cartridge.
- Verastem, Inc. VSTM gained 35.3% to $16.48 in pre-market trading. Verastem Oncology disclosed positive initial interim safety and efficacy results from RAMP 205 trial evaluating avutometinib plus defactinib in combination with gemcitabine and nab-paclitaxel in first-line metastatic pancreatic cancer.
- Nuburu, Inc. BURU shares rose 26.8% to $0.1759 in pre-market trading.
- Blue Star Foods Corp. BSFC shares gained 24.8% to $3.13 in pre-market trading. The company, earlier during the week, reported first-quarter financial results.
- Candel Therapeutics, Inc. CADL shares climbed 19.2% to $12.74 in pre-market trading. Candel Therapeutics reported prolonged overall survival in Phase 2 clinical trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in patients non-responsive to Immune Checkpoint Inhibitor (ICI) treatment at 2024 ASCO Annual Meeting.
- OneMedNet Corporation ONMD gained 17% to $1.72 in pre-market trading. OneMedNet shares jumped 208% on Thursday after the company highlighted a ‘five-fold expansion’ of its iRWD network and platform.
- Biora Therapeutics, Inc. BIOR gained 12.3% to $0.5579 in pre-market trading after tumbling 28% on Thursday.
Losers
- Soluna Holdings, Inc. SLNH shares declined 43.7% to $1.40 in pre-market trading after dipping 6% on Thursday.
- Sensei Biotherapeutics, Inc.. SNSE shares declined 31.5% to $1.00 in pre-market trading. Sensei Biotherapeutics presented clinical data from Phase 1 dose escalation study of SNS-101.
- Barnes & Noble Education, Inc. BNED shares dipped 24.1% to $0.60 in pre-market trading after the company reported preliminary FY24 consolidated revenue of approximately $1.567 billion.
- Summit Therapeutics Inc. SMMT shares fell 21.2% to $3.40 in pre-market trading.
- Akoustis Technologies, Inc. AKTS shares fell 15.8% to $0.1765 in pre-market trading after dipping 33% on Thursday. Akoustis recently announced a $10 million registered direct offering priced at-the-market under Nasdaq rules.
- Pineapple Energy Inc. PEGY shares fell 13.7% to $0.2090 in pre-market trading after jumping 61% on Thursday.
- Phoenix Motor Inc PEV shares fell 13% to $0.62 in pre-market trading. Phoenix Motor said it has rescheduled its first quarter 2024 earnings call to Thursday, May 30, at 4:30 p.m. ET.
- Roadzen Inc RDZN fell 12.6% to $3.36 in pre-market trading.
- Workday, Inc. WDAY shares declined 12.4% to $228.48 in pre-market trading. Workday posted upbeat earnings for its first quarter. However, the company lowered its forward guidance and now sees second-quarter subscription revenue of $1.895 billion and fiscal-year subscription revenue of between $7.7 billion and $7.725 billion.
- Intuit Inc. INTU shares fell 6.3% to $620.82 in pre-market trading. Intuit posted better-than-expected earnings for its third quarter and boosted its full-year outlook. However, the company issued weak earnings guidance for the current quarter.
Now Read This: SLB, First Solar And 2 Other Stocks Insiders Are Selling
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.